Medrad

Medrad, Inc. is a global medical device company that specializes in innovative solutions for diagnostic imaging and therapeutic procedures, particularly in radiology and cardiology. Founded in 1964 by Dr. M. Stephen Heilman, Medrad is known for its advanced power injectors that enhance imaging quality by delivering contrast agents during procedures. The company is headquartered in Warrendale, Pennsylvania, and operates as part of Bayer HealthCare’s Radiology division since its acquisition in 2006. Medrad offers a range of products and services, including contrast injection systems for CT, MRI, and angiography, as well as disposables and equipment services to support imaging operations. The company also provides endovascular devices for cardiovascular treatments and integrates digital solutions to improve imaging workflows. Medrad serves hospitals, medical imaging centers, and healthcare providers worldwide, with a significant portion of its revenue coming from North America. The company is committed to innovation, quality, and patient safety, and has received recognition for its excellence in business and healthcare technology.

• Employees 190
• Founded 1964
• Annual Revenue $625000000